Cohort Studyhigh evidence
Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment.
JAMA·July 14, 2026·PMID 42449500
Why it mattersPlasma p-tau217 provides time-specific absolute risk estimates for progression to cognitive impairment in cognitively unimpaired older adults, supporting its use in prognostic models and trial enrichment.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled